Why Green Plains (GPRE) Stock Is Down Today

Green Plains (NASDAQ: GPRE) shares fell about 7.9% after the company reported Q2 revenue of $446.2 million, down 19.3% year over year and below analysts’ $560 million estimate. GAAP EPS was $0.83, above consensus, but the revenue miss drove sentiment. UBS previously raised its price target to $20.

Original reporting
Published Aug 6, 2026, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 8:33 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$GPRE
Bearish
medium confidence
Mentioned
$GPRE
Relevance
7/10
alphai data visualization · based on financialcontent.com
Decision brief

The 30-second read

$GPREBearishMed
01

Why it matters

The market reaction is framed as an overemphasis on the top-line decline, suggesting traders may focus on revenue trajectory and demand indicators over adjusted earnings strength.

02

Market read

This is a single-name earnings reaction driven by a revenue miss, which can quickly reset near-term expectations for demand and cash-flow trajectory.

03

What to watch

The article does not provide segment drivers, guidance, or management commentary on why revenue fell, which could materially change the demand interpretation.

Relevance 7/10Novelty 6/10Timing: today’s afternoon selloff after Q2 results

Background

Green Plains is a biorefining/renewable energy company; the article highlights a prior UBS upgrade that increased EBITDA outlook, then contrasts it with the current Q2 revenue miss.

Company-level read

Ticker impact

$GPREBearishMedium confidence
Context

Green Plains shares fell 7.9% after Q2 revenue dropped 19.3% to $446.2M, missing the $560M analyst expectation despite EPS and EBITDA beats.

Expected impact

Bearish bias for the next few sessions as investors reprice revenue/demand risk; upside depends on follow-through commentary on demand and margins.

Evidence & confidence

The article attributes the move to the revenue miss and frames it as demand weakness, which typically outweighs an earnings beat in the short run.

Market effects

Renewable/biofuels investors may become more sensitive to revenue volatility and demand signals, not just adjusted profitability.

No specific regional spillover described.

No explicit global linkage beyond the renewable energy/biofuels demand narrative.

Counterpoint

The profit and adjusted EBITDA beat could indicate margin resilience, so the revenue miss may be temporary or timing-related rather than a structural demand collapse.

Key entities

  • Green Plains

    Subject of the article; Q2 revenue fell 19.3% to $446.2M and the stock dropped 7.9% on the miss.

  • UBS

    Previously raised its price target and EBITDA outlook for Green Plains, providing context for how expectations may have shifted.

Related articles

$GPREMed

Green Plains (NASDAQ:GPRE) Misses Q2 CY2026 Revenue Estimates

Green Plains (NASDAQ:GPRE) reported Q2 CY2026 revenue of $446.2 million, down 19.3% year on year, missing Wall Street’s estimates. GAAP profit was $0.83 per share, 27% above analysts’ consensus. The company reported an adjusted EBITDA margin of 20.9%, up from a year earlier, and said it beat EBITDA estimates by 2.2%. Shares rose 1.3% to $16.70 after results.

$GCOMed

102-year-old mall retailer quietly closes 25 stores

Genesco (GCO) closed 25 stores, including 17 Journeys locations, in Q2 fiscal 2027, per its earnings release. Net sales fell 3% YoY to $530M, with comparable sales down 1%. The company is shifting away from malls and remodeling stores to boost sales, with 4.0 Journeys stores showing 25% higher sales.

$EQIXMedAI 8/10

Equinix Is Doubling Down on AI Data Centers. How to Play EQIX Stock Here

Equinix (EQIX) reported Q2 revenue of $2.63B, up 16% YoY, beating estimates. AFFO was $11.78/share, up 19% YoY. The company raised full-year guidance and unveiled a multi-year growth plan. EQIX stock has surged 34% over the past year and offers a 1.98% dividend yield. Analysts rate it a 'Strong Buy' with an average price target of $1,232.19.